3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Small Cell Lung Carcinoma
2
Breast Neoplasms
2
Rhabdoid Tumor
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
47
Etoposide
46
durvalumab
28
atezolizumab
28
Cisplatin
21
Topotecan
19
pembrolizumab
15
PM 01183
15
Nivolumab
12
Specimen Handling
11
anlotinib
9
Radiotherapy
9
Paclitaxel
9
Drug Therapy
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
AMG 757
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
MLN 8237
×
1 year
×
Clear all
NCT06095505
2026-06-05
ALISCA-Lung1
Puma Biotechnology, Inc.
Phase 2
Recruiting
120 enrolled
NCT07465757
2026-03-12
ALISCA-Lung2
Puma Biotechnology, Inc.
Phase 2
Not yet recruiting
50 enrolled